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Results: 12.3% of the workers were suspected of being affected by OSAS. One or
more components of metabolic syndrome were present in 24.5% of cases. OSAS in
"healthy" workers was significantly associated with the presence of one or more
components of metabolic syndrome (OR=3.83; 95%CI 1.45-10.13) and with a
psychological disorders score in the highest quartile (OR= 4.67; 95%CI= 1.72-12.64).
Workers with suspected OSAS were reluctant to follow advice about undergoing further
tests under the NHS. However, in some cases, confirmation of the OSAS diagnosis
and subsequent treatment led to an improvement in metabolic condition.
Conclusion: Although participation in treatment was limited, anecdotal cases support
the idea that prevention of obstructive sleep apnea in the workplace might be useful for
workers' health.
Order of Authors: Sergio Garbarino
Nicola Magnavita, M.D.
Suggested Reviewers: Marko Elovainio
National Institute for Health and Welfare
marko.elovainio@thl.fi




She is really skilled in occupational medicine and epidemiology.
Opposed Reviewers:
Response to Reviewers: PONE-D-13-54485R1
‘Response to Reviewer’
Reviewer #1:
COMMENT 1: I would suggest to explain more clearly the design of the follow-up
study, and also to provide more information on the time of follow-up and how many
patients were lost.
Answer: Thank you for this observation that allowed us to clarify the method. The
workers in this sample are compelled to do a medical examination in the workplace
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
once a year. In the first visit, in 2012, workers were asked to participate voluntarily in
the Solaris project for the diagnosis of OSAS. During the visit in 2013, they were asked




For yourself and on behalf of all the
authors of this manuscript, please declare
below any competing interests as
described in the "PLoS Policy on
Declaration and Evaluation of Competing
Interests."
You are responsible for recognizing and
disclosing on behalf of all authors any
competing interest that could be
perceived to bias their work,
acknowledging all financial support and
any other relevant financial or competing
interests.
If no competing interests exist, enter: "The
authors have declared that no competing
interests exist."
If you have competing interests to
declare, please fill out the text box
completing the following statement: "I
have read the journal's policy and have
the following conflicts"
* typeset
"The authors have declared that no competing interests exist."
Financial Disclosure
Describe the sources of funding that have
supported the work. Please include
relevant grant numbers and the URL of
any funder's website. Please also include
this sentence: "The funders had no role in
study design, data collection and analysis,
decision to publish, or preparation of the
manuscript." If this statement is not
correct, you must describe the role of any
sponsors or funders and amend the
aforementioned sentence as needed.
* typeset
No current funding sources
Ethics Statement
All research involving human participants
must have been approved by the authors'
Workers signed written consent. The Ethics Committee of the Università Cattolica del
Sacro Cuore of Rome approved the study design and the consent form.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
institutional review board or equivalent
committee(s) and that board must be
named by the authors in the manuscript.
For research involving human
participants, informed consent must have
been obtained (or the reason for lack of
consent explained, e.g. the data were
analyzed anonymously) and all clinical
investigation must have been conducted
according to the principles expressed in
the Declaration of Helsinki. Authors
should submit a statement from their
ethics committee or institutional review
board indicating the approval of the
research. We also encourage authors to
submit a sample of a patient consent form
and may require submission of completed
forms on particular occasions.
All animal work must have been
conducted according to relevant national
and international guidelines. In
accordance with the recommendations of
the Weatherall report, "The use of non-
human primates in research" we
specifically require authors to include
details of animal welfare and steps taken
to ameliorate suffering in all work
involving non-human primates. The
relevant guidelines followed and the
committee that approved the study should
be identified in the ethics statement.
Please enter your ethics statement below
and place the same text at the beginning
of the Methods section of your manuscript
(with the subheading Ethics Statement).
Enter "N/A" if you do not require an ethics
statement.




Department of Public Health 
Catholic University School of Medicine 
Largo Gemelli 8, 00168 Roma 
Tel 3473300367 fax 0661909399 
e-mail: nicolamagnavita@gmail.com 
 
Rome, April 13, 2014 
 
 




Please find attached the 2
nd
 revision of our manuscript titled “Obstructive sleep 
apnea syndrome (OSAS), metabolic syndrome and mental health in small enterprise 
workers. Feasibility of an action for health”. (PONE-D-13-54485R1- 
EMID:97ec778b4072f669). 
We are pleased with the suggestion received from the reviewer. We hope that 
the revised manuscript is now acceptable for publication. However we are willing to do 
additional changes if necessary. 
A marked-up copy of the changes made from the previous article file as a 
'Revised Manuscript with Track Changes' file. This supplementary file, written  using 
'track changes' in MS Word is labeled “OSAS_Plos1_rev2_changes.docx”. 







‘Response to Reviewer’  
 
Reviewer #1:  
COMMENT 1: I would suggest to explain more clearly the design of the follow-up 
study, and also to provide more information on the time of follow-up and how many 
patients were lost. 
Answer: Thank you for this observation that allowed us to clarify the method. The 
workers in this sample are compelled to do a medical examination in the workplace 
once a year. In the first visit, in 2012, workers were asked to participate voluntarily in 
the Solaris project for the diagnosis of OSAS. During the visit in 2013, they were asked 




OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS), METABOLIC SYNDROME AND 
MENTAL HEALTH IN SMALL ENTERPRISE WORKERS. FEASIBILITY OF AN ACTION 
FOR HEALTH. 
 Sergio Garbarino1, Nicola Magnavita2. 
 
(1): Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal-Infantile Sciences 
(DINOGMI), and Department of Health Sciences, University of Genoa, Genoa, Italy. 
(2): Department of Public Health, Section of Occupational Medicine, Università Cattolica del Sacro Cuore, 
Roma, Italy.  
 
Corresponding author: Nicola Magnavita, Department of Public Health, Università Cattolica 
del Sacro Cuore, Largo Francesco Vito 1, 00168 Roma Italy 
e-mail: nicolamagnavita@gmail.com 
 
Short title: OSAS, metabolic syndrome and mental health. 
  
Manuscript




Objective: To determine the frequency of obstructive sleep apnea syndrome (OSAS), 
metabolic syndrome and common mental disorders in the working population of 11 small 
enterprises and the feasibility of a program of action for health. 
Method: The clinical risk of OSAS, the prevalence of metabolic syndrome, and the level of 
psychological disorders were assessed during routine medical examination at the 
workplace in 2012. The response to medical advice was assessed in 2013 
Results: 12.3% of the workers were suspected of being affected by OSAS. One or more 
components of metabolic syndrome were present in 24.5% of cases. OSAS in “healthy” 
workers was significantly associated with the presence of one or more components of 
metabolic syndrome (OR=3.83; 95%CI 1.45-10.13) and with a psychological disorders 
score in the highest quartile (OR= 4.67; 95%CI= 1.72-12.64). Workers with suspected 
OSAS were reluctant to follow advice about undergoing further tests under the NHS. 
However, in some cases, confirmation of the OSAS diagnosis and subsequent treatment 
led to an improvement in metabolic condition. 
Conclusion: Although participation in treatment was limited, anecdotal cases support the 
idea that prevention of obstructive sleep apnea in the workplace might be useful for 
workers’ health. 
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Obstructive sleep apnea syndrome (OSAS) is a common disorder caused by repeated 
episodes of airflow cessation (apneas) leading to arterial hypoxemia and sleep disruption 
[1]. This syndrome may have a number of consequences that deeply affect the quality of 
life, such as excessive daytime sleepiness, neurocognitive deterioration, and 
endocrinologic and metabolic effects [2]. Metabolic syndrome (MS) that is, itself, emerging 
as a highly prevalent public health problem, may be linked with OSAS. In fact, the 
presence of OSAS may increase the risk of developing some aspects of metabolic 
syndrome [3,4]. Moreover, clinical studies have shown a statistically significant correlation 
between the severity of OSAS and obesity, hypertension, diabetes mellitus, dyslipidaemia 
and metabolic syndrome [5]. However, little is known about the possible association 
between early-stage OSAS and MS components in active workers. 
Only limited knowledge is also available concerning the relationship between the presence 
of OSAS and psychological problems, although this syndrome is known to have an impact 
on neurocognitive functioning. Employees with OSAS run a major risk of long-term work 
disability caused by injuries and mental disorders [6]. Self-reported symptoms of OSAS 
are an independent risk factor for subsequent long-term sick leave and permanent work 
disability [7]. Both OSAS and hypertension related to this syndrome are significant 
predictors of impairment in workers [8]. However, all the above studies have focused on 
advanced cases of OSAS. Again, nothing is known about the mental health of active 
workers with previously undiagnosed OSAS. 
The aim of occupational medicine is to continuously improve the health of workers. For this 
reason, many health promotion campaigns are conducted in major companies. The main 
objective of these programs is to identify a risk factor that can be removed or minimized,  
thereby improving occupational health. OSAS may constitute a risk factor that requires an 
occupational prevention program. The first objective of this study was therefore to evaluate 
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the importance of OSAS as a risk factor. In order to do this we aim to assess the 
prevalence of OSAS among previously undiagnosed “healthy” subjects working in various 
fields and study the association between OSAS and MS components and mental health. 
Before undertaking a campaign to promote health, it is necessary to check the availability 
of resources in the country and productive area where you intend to introduce measures of 
prevention. In Italy, industrial production is characterized mainly by the presence of small 
businesses with fewer than 50 workers. Health promotion in these companies is more 
difficult than in large firms, owing to the lack of financial resources and organizational 
structures needed to support it. 
The second objective of our study was to ascertain whether a health promotion program, 
conducted by a clinician performing health surveillance without the use of additional 
resources can achieve measurable results in a sample of small companies in the Latium 




The baseline study was conducted in the first 4 months of 2012 on workers called for a 
routine medical examination in the workplace. The data in this study are partially drawn 
from the multicenter project SOLARIS (OSAS Screening of Workers in High Risk of Injury 
or Accident), coordinated by the University of Genoa. The workers belonged to 11 small 
companies, each employing between 10 and 51 workers. The productive sectors involved 
were: insurance, fuel distribution, home care, education, laboratory, wholesale, 
supermarkets, electronics and hotels. Subjects with a previous diagnosis of OSAS or 
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respiratory disorders were excluded from the investigation. 204 out of 209 eligible subjects 
(97.6%) participated in the survey. 
In 2013, 198 of these 204 workers (97.1%) were still working in the same company and 
were again called to medical examination in the workplace. During the visit, which is 
compulsory, workers who had been advised to do investigations for OSAS were asked the 
outcome. None of the subjects with suspected OSAS was lost at follow-up. The overall 
participation rate at follow-up was 94.7%. 
Questionnaires. 
Within the project, SOLARIS workers were asked to complete two short questionnaires: 
the sleep disorder score (SDS) [9], and the Epworth Sleepiness Scale (ESS) [10].  
The SDS test, used to aid diagnosis of OSAS, contains 4 items that respectively refer to 
nocturnal snoring, apnea, nocturnal awakenings, and dry mouth in the morning. A global 
score was evaluated for each subject by averaging the numeric values associated with all  
4 items, and an SDS score of over 2 was considered to be pathological. 
The ESS test is a simple instrument for evaluating excessive daytime sleepiness. It is an 
eight-item questionnaire which provides a simple and inexpensive measurement of 
tendency to sleep in different daily life situations. For each situation, subjects could 
express a range of numeric values, from 0 to 3, thus obtaining a total score ranging from 0 
(no daytime sleepiness) to 24 (the highest level of daytime sleepiness). Normally, ESS 
scores of over 10 were considered to indicate excessive daytime sleepiness [11]. 
However, studies performed with the Italian version of the questionnaire showed that 12 
and 17 were the ESS cut-off scores with the best sensitivity and specificity [12]. 
Psychological distress was measured by the Italian version [13] of the General Health 
Questionnaire [14]. This test is made up of 12-items. Each item is accompanied by four 
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possible responses which can be scored on a Likert scale from 1 to 4.The total score can 
yield a continuous variable ranging from 12 to 48. In the present study, GHQ12 had a 
Cronbach alpha= 0.849. For the purposes of statistical analysis, the values obtained with 
the GHQ12 were divided into quartiles and the highest quartile was taken as an indicator 
of psychological problems. The population was thus divided into two groups: those with 
psychological problems (GHQ in the highest quartile, i.e. >24) and all the others. 
In addition to gender and age, each subject declared smoking status (current smoker / 
non-smoker), alcohol use (divided into four classes: 1 = I do not drink alcohol; 2 = I drink 
up to seven units of alcohol per week, i.e. one in the daytime; 3 = I drink from eight to 
sixteen units of alcohol per week, i.e. two per day; 4 = I drink more than sixteen units per 
week, i.e. more than 2 per day); physical exercise (at least 30 minutes of vigorous physical 
activity, 1 = at least 3 times a week; 2 = twice a week; 3 = once a week; 4 = never). 
During medical examinations, body mass index (BMI; kg/m2), neck circumference (NC; 
cm), thyromental, or neck-chin angle (N-CA; grades) [15], and visibility of pharyngeal 
structures according to the Mallampati classification [16] were measured. The Mallampati 
classification is a rough estimate of tongue size related to the oral cavity.  This was initially 
proposed as a simple, reproducible, and reliable preanesthetic airway assessment 
method. Besides being a sign of difficult tracheal intubation, Mallampati class 3 or 4 is an 
independent predictor for the presence of obstructive sleep apnea [17]. 
OSAS was suspected when there were at least 2 positive responses to the sleep disorders 
scale (SDS) associated with at least 1 above the anthropomorphic threshold measured 
among the following parameters: BMI (>30kg/m2); NC (> 43 cm in male and >41 cm in 
female workers); N-CA (> 110°) and Mallampati (3 or 4). 
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After collecting the Solaris project data, subjects were further examined to evaluate the 
presence  of metabolic syndrome. According to the International Diabetes Federation (IDF) 
guide [18], metabolic syndrome is identified by the following criteria: central obesity 
(defined as BMI>30 kg/m2, or increased waist circumference with ethnicity-specific values); 
elevated triglyceride level: > 150 mg/dL (1.7 mmol/L), or specific treatment for this lipid 
abnormality; reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males, < 50 mg/dL 
(1.29 mmol/L) in females, or specific treatment for this lipid abnormality; high blood 
pressure (BP): systolic BP > 130 or diastolic BP >85 mm Hg, or treatment of previously 
diagnosed hypertension; high fasting plasma glucose (FPG): >100 mg/dL (5.6 mmol/L), or 
previously diagnosed type 2 diabetes. 
Workers with suspected OSAS were invited to undergo second level studies (specialist 
neurological or pulmonary examination and possibly, depending on the advice of the 
specialist, imaging studies such as polysomnography (PSG). Adherence to this invitation 
was verified a year later during routine medical examination in the workplace. 
The article metadata of this study are deposited in Dryad. 
Ethics statement. 
Workers signed written consent. The Ethics Committee of the Università Cattolica del 
Sacro Cuore of Rome approved the study design and the consent form. 
Statistics. 
Analyses were performed using IBM/ SPSS for Windows (rel. 20.0). First of all, the data 
collected were analyzed using common statistics. The results obtained for the two genders 
were compared using the Student's t test for independent data (comparison of means) or 
the chi-square test (comparison of proportions). Logistic regression analysis was used to 
study the association between suspected OSAS and the presence of at least one 
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metabolic syndrome components (obesity, hypertension, dyslipidemia, diabetes). The 
association between suspected OSAS and the presence of psychological problems 
(GHQ12 score in the highest quartile) was also studied using logistic regression analysis. 
In both the aforementioned analyses, personal factors (age, sex, smoking, alcohol use, 
physical exercise) were entered as confounding factors. 
 
Results 
The clinical and demographic characteristics of the subjects, both as a group and 
classified by gender, are reported in Table 1. The descriptive statistics indicate a group of 
experienced workers (13.8±9.1 years) with a low number (37.3%) of smokers and a 
normal mean BMI range (24.5±4.3 Kg/cm2). 4.3% (n=7) of subjects had an ESS score>10, 
indicating daytime sleepiness. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Please insert Table 1 about here 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
In the gender comparison, males reported a significantly higher consumption of alcohol 
than females (p<0.011). A greater frequency of enlarged neck circumference, increased 
neck-chin angle, and Mallampati grade 3-4 (p<0.024) was found in males than in females. 
The score of the SDS questionnaire on sleep disorders was significantly higher in males 
than in females (p<0.025), whereas no significant difference between genders was 




We identified 25 subjects (12.3%) with a clinical suspicion of OSAS. None of the workers 
reached the level of 17 points on the ESS scale, considered to be the cut-off point for 
greater diagnostic specificity. Only 3 workers with suspected OSAS were affected by mild 
sleepiness (ESS score >10). Two of the latter had parameters indicating a complete 
metabolic syndrome (obesity, plus two other metabolic disorders).   
In data regarding MS only, 50 subjects (24.5%) presented one or more risk factors 
(obesity, dyslipidemia, hypertension, or diabetes). The prevalence of workers with suspect 
OSAS having at least one MS components was 52.0%. Logistic regression analysis 
showed that clinical suspicion of OSAS was significantly associated with the presence of 
metabolic disorders (OR=3.83; 95%CI 1.45-10.13) in a model that included other personal 
factors (sex, age, smoking habit, alcohol consumption, and sedentary life). Age, male 
gender and lack of physical activity were significantly associated with the presence of 
metabolic syndrome components (Table 2). 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Please insert Table 2 about here 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
Psychological problems, as measured by the GHQ12 mean score, were significantly 
higher in OSAS than in non-OSAS subjects (25.7+7.2 vs. 21.8+4.0, test t p<0.000). 
Workers with OSAS had a significantly increased risk of having a GHQ12 score in the 
highest quartile, (OR= 4.67; 95%CI= 1.72-12.64) in a multivariate logistic regression model 
that included age, gender, smoking habit, alcohol use, and physical activity (Table 3). 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Please insert Table 3 about here 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
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During the follow-up survey carried out in 2013, all workers who had been sent to their 
own doctors with a diagnosis of suspected OSAS, and an invitation to perform additional 
tests under the NHS, were questioned on the outcome. A worker with severe systolic-
diastolic hypertension resistant to therapy had been diagnosed with OSAS. Effective 
treatment of OSAS with continuous positive airway pressure for 3 months had significantly 
reduced blood pressure. Two workers with abdominal obesity had received confirmation of 
the OSAS diagnosis and were following positive airway pressure therapy associated with 
nutritional therapy. One worker had the OSAS diagnosis confirmed and had been treated 
with mandibular advance device therapy. In the case of another worker who had 
undergone further medical investigations, the diagnosis of OSAS had been ruled out. The 
majority of workers (20/25 = 80%) had not heeded the invitation of the occupational 
physician and had not carried out any further investigation. The reasons most frequently 
given for failing to adhere to the invitation were lack of time, lack of health service 




The present study confirms that obstructive sleep apnea is a rather frequent and 
underdiagnosed condition, and that daytime sleepiness is not uncommon. This is very 
worrisome. Reduction in vigilance and attention could be fatal in some job categories such 
as drivers and operators of dangerous machines. Moreover, the risk of cardiovascular 




Although this is a small-scale study, our assumptions are also valid for selected 
populations. As we know, the occupational physician can only examine healthy workers. In 
fact, medical examination in the workplace is not possible during illness, even when it is of 
short duration. This can cause an undervaluation of the workers’ state of illness. Moreover, 
workers are selected from the general population. In fact, the so-called "healthy worker 
effect" refers precisely to the fact that the occupational population have a better level of 
health than the general population. Although we tested a selected population, we found a 
12.3% prevalence of suspected OSAS, and 4.3% of workers reported feeling very drowsy 
during work. 
In this sample, 24.5% suffered from obesity, or high blood pressure, diabetes or 
dyslipidemia. OSAS was significantly associated with these metabolic disorders. The 
cross-sectional nature of these observations prevents us from making causal 
considerations, however a recent review [19] shows that obesity predisposes to OSAS, 
and the increasing prevalence of OSAS is influenced by the worldwide ongoing epidemic 
of obesity [20]. It has been observed, indeed, that obesity and OSAS tend to cluster in the 
same workplace [21]. Many markers of cardiovascular risk, such as sympathetic activation, 
systemic inflammation, and endothelial dysfunction, are significantly increased in obese 
patients with OSAS compared to those without OSAS [22-25]. This fact suggests that 
OSAS is not simply an epiphenomenon of obesity. Moreover, findings from animal models 
and patients with OSAS show that intermittent hypoxia exacerbates the metabolic 
dysfunction of obesity, augmenting insulin resistance and nonalcoholic fatty liver disease 
[26, 27]. In patients with the metabolic syndrome, OSAS is independently associated with 
increased glucose and triglyceride levels as well as markers of inflammation, arterial 
stiffness, and atherosclerosis [28, 29]. Several cohort studies have consistently shown that 
OSAS is associated with increased cardiovascular mortality, independent of obesity [30-
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32]. Taken together, these results support the concept that OSA exacerbates the 
cardiometabolic risk attributed to obesity and metabolic syndrome. However, it has been 
demonstrated that recognition and treatment of OSAS may decrease the cardiovascular 
risk in patients with metabolic syndrome [33-36].  
An interesting result of our study was the association observed between suspected OSAS 
and psychological problems. To our knowledge, this aspect has never been studied in 
previous research on patients with suspected OSAS although this syndrome is known to 
be linked to a number of complications such as psychiatric conditions that significantly 
impair the quality of life. For example, OSAS may be associated with depression in 
adolescents and with Down Syndrome in young adults [37]. These macroscopic effects are 
the result of deep physiological alterations. In fact, at cellular level, OSAS can cause 
intermittent hypoxia, hormonal imbalance, and/or systemic inflammation which may 
influence cognitive functions [38]. However, in patients with OSAS, mental fatigue and 
cognitive impairment are directly correlated to the severity of nocturnal disordered 
breathing [39]. Clearly, the severity of the pathology is very important because a cognitive 
consequence is expected only in severe and advanced cases, not in recently diagnosed 
OSAS patients with minimal co-morbidities [40], or in suspected cases identified during 
screening.  
Mood disorders in patients with OSAS have also been studied, especially in relation to the 
way in which these problems may affect adherence to treatment; however the nature of 
the relationship between OSAS and depression and anxiety is still unclear [41]. In fact, 
recent research on depression and anxiety in obstructive sleep apnea syndrome led to 
inconsistent findings: prevalence figures fluctuated considerably for both depression (7-
63%) and anxiety (11-70%) [42]. Moreover, the  reported associations were often 
contrasting. In some cross-sectional studies, OSAS patients had higher scores for 
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depression and anxiety than the control group [43], while in other studies, OSAS was not 
associated with severe symptoms of  depression and anxiety [44]. These differences are 
probably due to the methods used to measure psychological disorders. 
In the present study, we used a particularly sensitive tool to measure mental health. The 
GHQ is possibly the most common assessment of mental well-being [45]. In fact, it is used 
to detect minor psychiatric (non-psychotic) disorders in the general population and within 
community or non-psychiatric clinical settings. It focuses on two main areas: inability to 
carry out normal functions and the appearance of new and distressing psychological 
phenomena. The GHQ assesses the respondent’s current state and determines whether it 
differs from his or her usual state. Therefore, it is sensitive to short-term psychiatric 
disorders, but not to long-standing attributes of the respondent. This instrument, which was 
designed to detect psychiatric morbidity, has also performed very well in trans-cultural 
comparisons of community-based populations [46]. We can therefore assume that the 
GHQ measures an early, and possibly transient worsening of psychological conditions in 
workers with recent onset of sleep apnea. We conclude, in accordance with the literature, 
that the relationships between early-stage OSA and psychological disturbances are weak 
but significant. 
In our study, prevalence values for metabolic syndrome were lower than those estimated 
in the general Italian population and other industrialized countries. The third National 
Health and Nutrition Examination Survey (NHANES III) recorded a 21.8% prevalence of 
metabolic syndrome in the total population [47]. In NHANES III the prevalence of 
abdominal obesity was approximately 50% in females and 30% in males. This was also 
higher than the value found in our study, as were the US population levels of impaired 
HDL-cholesterol, hyperglycemia and hypertension. The few data available for Italy confirm 
that metabolic syndrome and its components occur more frequently than was observed in 
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our sample. The Italian Longitudinal Study on Aging (ILSA) reported a metabolic syndrome 
prevalence of 25.9% [48]. A study conducted in the Marche Region of Italy found a 
metabolic syndrome prevalence of 11.5% in the 36 to 42 age group and of 22.5% in 
subjects between the age of 43 and 60 years [49]. This demonstrated that in our sample 
group at least, the health level of employees was higher than that of the general population 
– a fact that must be taken into account in the planning of action for health. It also 
indicated that the subjects taking part in our study were not prompted in because they 
were suffering from one of the pathologies under investigation. This was important since 
we know that being affected by any morbid condition induces individuals to be more 
precise when recalling all the possible causal factors for that illness. This phenomenon, 
known as “recall bias”, can give rise to fictitious associations. Compared with what may 
occur in case-control studies, the limited number of sick subjects in our survey reduced the 
impact of such an effect. 
Unfortunately, in our study, the majority of workers with suspected OSAS failed to respond 
to advice suggesting they undergo other tests to confirm the diagnosis. In the few cases in 
which subjects followed the advice of the occupational physician, a significant clinical 
improvement was observed. 
This experience demonstrated that health promotion during compulsory health surveillance 
is effective in only a limited number of workers. The main reason for ignoring the 
physician’s advice seemed to be unawareness on the part of the workers of the 
importance of the detrimental effects of OSAS. A multilevel effort that includes specific 
information about the health risks associated with OSAS and incentives for workers who 
participate in the programs proposed, might effectively help to safeguard workers’ health. 
Since small enterprises lack financial resources and training structures, these services 
must be provided by public or consortium facilities. 
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The main limitation of this study concerned sample selection, as all the companies were 
located in the same region and were under the health surveillance of the same doctor 
(NM). These conditions obviously prevented us from extending our findings to other 
situations. One of the strengths of the study was the high level of participation at baseline. 
Another  strength was the inclusion of general workers in the study population. Previous 
studies on the prevalence and risk factors of occupational OSAS had mainly targeted at-
risk workers, so that results were not applicable to a more general population of workers. A 
further strength was the broad set of clinical issues examined; these included an objective 
evaluation of the risk of OSAS, an assessment of sleepiness, blood tests and clinical 
examination to diagnose metabolic syndrome and screening for psychological disorders. 
All these tests were included during the routine medical surveillance of workers without a 
significant burden of time for the performance of medical examinations.  
The data collected show that OSAS is an important risk factor that is widely prevalent in 
the general population of workers, and that this syndrome is strongly correlated with  
metabolic syndrome and mental disorders. It is therefore an ideal candidate for health 
intervention. 
Health promotion programs conducted in small enterprises and based exclusively on 
services provided by the NHS, without a spending commitment for training and incentives 
on the part of employers, have a beneficial but limited impact on the health of workers. 
Only a few workers accepted the invitation of the occupational physician to undergo more 
specialized tests to confirm or refute the diagnosis of OSAS. However, excellent results 
were obtained for those who followed this advice. We are confident that a prevention 
program comprising educational, health and organizational activities could actually prevent 
OSAS and its physical and psychological consequences in the general population of 
workers.   
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Table 1. Medical and demographic data for participants. 
 
Variable Male Female p Whole group 
Gender, N (%) 108 (52.9) 96 (47.1)  204 (100) 
Age, years (mean + s.d.) 41.3 + 9.4 40.8 + 9.0 n.s.1 41.1 + 9.2 
Length of work, years 13.2 + 9.7 14.6 + 8.3 n.s.1 13.8 + 9.1 
Smoker, N (%) 46 (42.6) 30 (31.2) n.s.2 76 (37.3) 
Alcohol, 1-7 units/week 51 (47.7) 28 (29.2) <0.0112 79 (38.9) 
Alcohol, 8-16 units/week   7 (6.5)   4 (4.2) 11 (5.4) 
BMI (mean + s.d.) 25.8+3.7 23.0+4.5 <0.0001 24.5+4.3 
Enlarged neck circumference 21 (19.4)  2 (2.1) <0.0002 23 (11.3) 
Increased neck-chin angle 44 (40.7) 22 (22.9) <0.0072 66 (32.4) 
Mallampati grade 3 or 4 24 (22.2) 10 (10.4) <0.0242 34 (16.7) 
ESS (range 0-24) 3.5 + 2.5 3.9 + 3.3 n.s.1 3.7 + 2.9 
SDS (range 0-4) 0.99+1.0 0.69+0.85 <0.0251 0.85 + 0.97 
GHQ (range 12-48) 21.9 + 3.5 22.7 + 5.6 n.s.1 22.2 + 4.6 
 





Table 2. Association between suspected OSAS and personal factors (age, sex, smoking habit, 
alcohol use, lack of physical exercise) and the presence of at least one components of metabolic 
syndrome (obesity, hypertension, dyslipidemia, diabetes). 
 
 
 Predictors  p value 
 OR 95%CI  
OSAS  3.831 1.449-10.129  0.007 
Age 1.073 1.031-1.116  0.001 
Sex 0.395 0.185-0.842  0.016 
Smoker 1.349 0.645-2.822  0.426 
Alcohol use 0.777 0.414-1.458  0.432 
Lack of physical 
activity 
1.878 





Table 3. Associations between suspected OSAS and personal factors (age, sex, smoking habit, 
alcohol use, lack of physical exercise) and GHQ12 score in the highest quartile. 
 
 Predictors p value 
 OR 95%CI 
OSAS 4.668 1.724-12.640 0.002 
Age 1.015 0.975-1.057 0.463 
Sex 3.656 1.619-8.257 0.002 
Smoker 1.306 0.604-2.826 0.497 
Alcohol use 1.236 0.667-2.290 0.500 
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Objective: To determine the frequency of obstructive sleep apnea syndrome (OSAS), 
metabolic syndrome and common mental disorders in the working population of 11 small 
enterprises and the feasibility of a program of action for health. 
Method: The clinical risk of OSAS, the prevalence of metabolic syndrome, and the level of 
psychological disorders were assessed during routine medical examination at the 
workplace. in 2012. The response to medical advice was assessed in 2013. 
Results: 12.3% of the workers were suspected of being affected by OSAS. One or more 
components of metabolic syndrome were present in 24.5% of cases. OSAS in “healthy” 
workers was significantly associated with the presence of one or more components of 
metabolic syndrome (OR=3.83; 95%CI 1.45-10.13) and with a psychological disorders 
score in the highest quartile (OR= 4.67; 95%CI= 1.72-12.64). Workers with suspected 
OSAS were reluctant to follow advice about undergoing further tests under the NHS. 
However, in some cases, confirmation of the OSAS diagnosis and subsequent treatment 
led to an improvement in metabolic condition. 
Conclusion: Although participation in treatment was limited, anecdotal cases support the 
idea that prevention of obstructive sleep apnea in the workplace might be useful for 
workers’ health. 
 
Keywords: obstructive sleep apnea syndrome, metabolic syndrome, mental health, health 
promotion, workplace, sleepiness, occupational injury and disease, hypertension, obesity, 




Obstructive sleep apnea syndrome (OSAS) is a common disorder caused by repeated 
episodes of airflow cessation (apneas) leading to arterial hypoxemia and sleep disruption 
[1]. This syndrome may have a number of consequences that deeply affect the quality of 
life, such as excessive daytime sleepiness, neurocognitive deterioration, and 
endocrinologic and metabolic effects [2]. Metabolic syndrome (MS) that is, itself, emerging 
as a highly prevalent public health problem, may be linked with OSAS. In fact, the 
presence of OSAS may increase the risk of developing some aspects of metabolic 
syndrome [3,4]. Moreover, clinical studies have shown a statistically significant correlation 
between the severity of OSAS and obesity, hypertension, diabetes mellitus, dyslipidaemia 
and metabolic syndrome [5]. However, little is known about the possible association 
between early-stage OSAS and MS components in active workers. 
Only limited knowledge is also available concerning the relationship between the presence 
of OSAS and psychological problems, although this syndrome is known to have an impact 
on neurocognitive functioning. Employees with OSAS run a major risk of long-term work 
disability caused by injuries and mental disorders [6]. Self-reported symptoms of OSAS 
are an independent risk factor for subsequent long-term sick leave and permanent work 
disability [7]. Both OSAS and hypertension related to this syndrome are significant 
predictors of impairment in workers [8]. However, all the above studies have focused on 
advanced cases of OSAS. Again, nothing is known about the mental health of active 
workers with previously undiagnosed OSAS. 
The aim of occupational medicine is to continuously improve the health of workers. For this 
reason, many health promotion campaigns are conducted in major companies. The main 
objective of these programs is to identify a risk factor that can be removed or minimized,  
thereby improving occupational health. OSAS may constitute a risk factor that requires an 
occupational prevention program. The first objective of this study was therefore to evaluate 
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the importance of OSAS as a risk factor. In order to do this we aim to assess the 
prevalence of OSAS among previously undiagnosed “healthy” subjects working in various 
fields and study the association between OSAS and MS components and mental health. 
Before undertaking a campaign to promote health, it is necessary to check the availability 
of resources in the country and productive area where you intend to introduce measures of 
prevention. In Italy, industrial production is characterized mainly by the presence of small 
businesses with fewer than 50 workers. Health promotion in these companies is more 
difficult than in large firms, owing to the lack of financial resources and organizational 
structures needed to support it. 
The second objective of our study was to ascertain whether a health promotion program, 
conducted by a clinician performing health surveillance without the use of additional 
resources can achieve measurable results in a sample of small companies in the Latium 




The baseline study was conducted in the first 4 months of 2012 on workers called for a 
routine medical examination in the workplace. The data in this study are partially drawn 
from the multicenter project SOLARIS (OSAS Screening of Workers in High Risk of Injury 
or Accident), coordinated by the University of Genoa. The workers belonged to 11 small 
companies, each employing between 10 and 51 workers. The productive sectors involved 
were: insurance, fuel distribution, home care, education, laboratory, wholesale, 
supermarkets, electronics and hotels. Subjects with a previous diagnosis of OSAS or 
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respiratory disorders were excluded from the investigation. 204 out of 209 eligible subjects 
(97.6%) participated in the survey. 
In 2013, 198 of these 204 workers (97.1%) were still working in the same company and 
were again called to medical examination in the workplace. During the visit, which is 
compulsory, workers who had been advised to do investigations for OSAS were asked the 
outcome. None of the subjects with suspected OSAS was lost at follow-up. The overall 
participation rate at follow-up was 94.7%. 
Questionnaires. 
Within the project, SOLARIS workers were asked to complete two short questionnaires: 
the sleep disorder score (SDS) [9], and the Epworth Sleepiness Scale (ESS) [10].  
The SDS test, used to aid diagnosis of OSAS, contains 4 items that respectively refer to 
nocturnal snoring, apnea, nocturnal awakenings, and dry mouth in the morning. A global 
score was evaluated for each subject by averaging the numeric values associated with all  
4 items, and an SDS score of over 2 was considered to be pathological. 
The ESS test is a simple instrument for evaluating excessive daytime sleepiness. It is an 
eight-item questionnaire which provides a simple and inexpensive measurement of 
tendency to sleep in different daily life situations. For each situation, subjects could 
express a range of numeric values, from 0 to 3, thus obtaining a total score ranging from 0 
(no daytime sleepiness) to 24 (the highest level of daytime sleepiness). Normally, ESS 
scores of over 10 were considered to indicate excessive daytime sleepiness [11]. 
However, studies performed with the Italian version of the questionnaire showed that 12 
and 17 were the ESS cut-off scores with the best sensitivity and specificity [12]. 
Psychological distress was measured by the Italian version [13] of the General Health 
Questionnaire [14]. This test is made up of 12-items. Each item is accompanied by four 
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possible responses which can be scored on a Likert scale from 1 to 4.The total score can 
yield a continuous variable ranging from 12 to 48. In the present study, GHQ12 had a 
Cronbach alpha= 0.849. For the purposes of statistical analysis, the values obtained with 
the GHQ12 were divided into quartiles and the highest quartile was taken as an indicator 
of psychological problems. The population was thus divided into two groups: those with 
psychological problems (GHQ in the highest quartile, i.e. >24) and all the others. 
In addition to gender and age, each subject declared smoking status (current smoker / 
non-smoker), alcohol use (divided into four classes: 1 = I do not drink alcohol; 2 = I drink 
up to seven units of alcohol per week, i.e. one in the daytime; 3 = I drink from eight to 
sixteen units of alcohol per week, i.e. two per day; 4 = I drink more than sixteen units per 
week, i.e. more than 2 per day); physical exercise (at least 30 minutes of vigorous physical 
activity, 1 = at least 3 times a week; 2 = twice a week; 3 = once a week; 4 = never). 
During medical examinations, body mass index (BMI; kg/m2), neck circumference (NC; 
cm), thyromental, or neck-chin angle (N-CA; grades) [15], and visibility of pharyngeal 
structures according to the Mallampati classification [16] were measured. The Mallampati 
classification is a rough estimate of tongue size related to the oral cavity.  This was initially 
proposed as a simple, reproducible, and reliable preanesthetic airway assessment 
method. Besides being a sign of difficult tracheal intubation, Mallampati class 3 or 4 is an 
independent predictor for the presence of obstructive sleep apnea [17]. 
OSAS was suspected when there were at least 2 positive responses to the sleep disorders 
scale (SDS) associated with at least 1 above the anthropomorphic threshold measured 
among the following parameters: BMI (>30kg/m2); NC (> 43 cm in male and >41 cm in 
female workers); N-CA (> 110°) and Mallampati (3 or 4). 
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After collecting the Solaris project data, subjects were further examined to evaluate the 
presence  of metabolic syndrome. According to the International Diabetes Federation (IDF) 
guide [18], metabolic syndrome is identified by the following criteria: central obesity 
(defined as BMI>30 kg/m2, or increased waist circumference with ethnicity-specific values); 
elevated triglyceride level: > 150 mg/dL (1.7 mmol/L), or specific treatment for this lipid 
abnormality; reduced HDL cholesterol: < 40 mg/dL (1.03 mmol/L) in males, < 50 mg/dL 
(1.29 mmol/L) in females, or specific treatment for this lipid abnormality; high blood 
pressure (BP): systolic BP > 130 or diastolic BP >85 mm Hg, or treatment of previously 
diagnosed hypertension; high fasting plasma glucose (FPG): >100 mg/dL (5.6 mmol/L), or 
previously diagnosed type 2 diabetes. 
Workers with suspected OSAS were invited to undergo second level studies (specialist 
neurological or pulmonary examination and possibly, depending on the advice of the 
specialist, imaging studies such as polysomnography (PSG). Adherence to this invitation 
was verified a year later during routine medical examination in the workplace. 
The article metadata of this study are deposited in Dryad. 
Ethics statement. 
Workers signed written consent. The Ethics Committee of the Università Cattolica del 
Sacro Cuore of Rome approved the study design and the consent form. 
Statistics. 
Analyses were performed using IBM/ SPSS for Windows (rel. 20.0). First of all, the data 
collected were analyzed using common statistics. The results obtained for the two genders 
were compared using the Student's t test for independent data (comparison of means) or 
the chi-square test (comparison of proportions). Logistic regression analysis was used to 
study the association between suspected OSAS and the presence of at least one 
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metabolic syndrome components (obesity, hypertension, dyslipidemia, diabetes). The 
association between suspected OSAS and the presence of psychological problems 
(GHQ12 score in the highest quartile) was also studied using logistic regression analysis. 
In both the aforementioned analyses, personal factors (age, sex, smoking, alcohol use, 
physical exercise) were entered as confounding factors. 
 
Results 
The clinical and demographic characteristics of the subjects, both as a group and 
classified by gender, are reported in Table 1. The descriptive statistics indicate a group of 
experienced workers (13.8±9.1 years) with a low number (37.3%) of smokers and a 
normal mean BMI range (24.5±4.3 Kg/cm2). 4.3% (n=7) of subjects had an ESS score>10, 
indicating daytime sleepiness. 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Please insert Table 1 about here 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
In the gender comparison, males reported a significantly higher consumption of alcohol 
than females (p<0.011). A greater frequency of enlarged neck circumference, increased 
neck-chin angle, and Mallampati grade 3-4 (p<0.024) was found in males than in females. 
The score of the SDS questionnaire on sleep disorders was significantly higher in males 
than in females (p<0.025), whereas no significant difference between genders was 




We identified 25 subjects (12.3%) with a clinical suspicion of OSAS. None of the workers 
reached the level of 17 points on the ESS scale, considered to be the cut-off point for 
greater diagnostic specificity. Only 3 workers with suspected OSAS were affected by mild 
sleepiness (ESS score >10). Two of the latter had parameters indicating a complete 
metabolic syndrome (obesity, plus two other metabolic disorders).   
In data regarding MS only, 50 subjects (24.5%) presented one or more risk factors 
(obesity, dyslipidemia, hypertension, or diabetes). The prevalence of workers with suspect 
OSAS having at least one MS components was 52.0%. Logistic regression analysis 
showed that clinical suspicion of OSAS was significantly associated with the presence of 
metabolic disorders (OR=3.83; 95%CI 1.45-10.13) in a model that included other personal 
factors (sex, age, smoking habit, alcohol consumption, and sedentary life). Age, male 
gender and lack of physical activity were significantly associated with the presence of 
metabolic syndrome components (Table 2). 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Please insert Table 2 about here 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
Psychological problems, as measured by the GHQ12 mean score, were significantly 
higher in OSAS than in non-OSAS subjects (25.7+7.2 vs. 21.8+4.0, test t p<0.000). 
Workers with OSAS had a significantly increased risk of having a GHQ12 score in the 
highest quartile, (OR= 4.67; 95%CI= 1.72-12.64) in a multivariate logistic regression model 
that included age, gender, smoking habit, alcohol use, and physical activity (Table 3). 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 
Please insert Table 3 about here 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
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During the follow-up survey carried out in 2013, all workers who had been sent to their 
own doctors with a diagnosis of suspected OSAS, and an invitation to perform additional 
tests under the NHS, were questioned on the outcome. A worker with severe systolic-
diastolic hypertension resistant to therapy had been diagnosed with OSAS. Effective 
treatment of OSAS with continuous positive airway pressure for 3 months had significantly 
reduced blood pressure. Two workers with abdominal obesity had received confirmation of 
the OSAS diagnosis and were following positive airway pressure therapy associated with 
nutritional therapy. One worker had the OSAS diagnosis confirmed and had been treated 
with mandibular advance device therapy. In the case of another worker who had 
undergone further medical investigations, the diagnosis of OSAS had been ruled out. The 
majority of workers (20/25 = 80%) had not heeded the invitation of the occupational 
physician and had not carried out any further investigation. The reasons most frequently 
given for failing to adhere to the invitation were lack of time, lack of health service 




The present study confirms that obstructive sleep apnea is a rather frequent and 
underdiagnosed condition, and that daytime sleepiness is not uncommon. This is very 
worrisome. Reduction in vigilance and attention could be fatal in some job categories such 
as drivers and operators of dangerous machines. Moreover, the risk of cardiovascular 




Although this is a small-scale study, our assumptions are also valid for selected 
populations. As we know, the occupational physician can only examine healthy workers. In 
fact, medical examination in the workplace is not possible during illness, even when it is of 
short duration. This can cause an undervaluation of the workers’ state of illness. Moreover, 
workers are selected from the general population. In fact, the so-called "healthy worker 
effect" refers precisely to the fact that the occupational population have a better level of 
health than the general population. Although we tested a selected population, we found a 
12.3% prevalence of suspected OSAS, and 4.3% of workers reported feeling very drowsy 
during work. 
In this sample, 24.5% suffered from obesity, or high blood pressure, diabetes or 
dyslipidemia. OSAS was significantly associated with these metabolic disorders. The 
cross-sectional nature of these observations prevents us from making causal 
considerations, however a recent review [19] shows that obesity predisposes to OSAS, 
and the increasing prevalence of OSAS is influenced by the worldwide ongoing epidemic 
of obesity [20]. It has been observed, indeed, that obesity and OSAS tend to cluster in the 
same workplace [21]. Many markers of cardiovascular risk, such as sympathetic activation, 
systemic inflammation, and endothelial dysfunction, are significantly increased in obese 
patients with OSAS compared to those without OSAS [22-25]. This fact suggests that 
OSAS is not simply an epiphenomenon of obesity. Moreover, findings from animal models 
and patients with OSAS show that intermittent hypoxia exacerbates the metabolic 
dysfunction of obesity, augmenting insulin resistance and nonalcoholic fatty liver disease 
[26, 27]. In patients with the metabolic syndrome, OSAS is independently associated with 
increased glucose and triglyceride levels as well as markers of inflammation, arterial 
stiffness, and atherosclerosis [28, 29]. Several cohort studies have consistently shown that 
OSAS is associated with increased cardiovascular mortality, independent of obesity [30-
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32]. Taken together, these results support the concept that OSA exacerbates the 
cardiometabolic risk attributed to obesity and metabolic syndrome. However, it has been 
demonstrated that recognition and treatment of OSAS may decrease the cardiovascular 
risk in patients with metabolic syndrome [33-36].  
An interesting result of our study was the association observed between suspected OSAS 
and psychological problems. To our knowledge, this aspect has never been studied in 
previous research on patients with suspected OSAS although this syndrome is known to 
be linked to a number of complications such as psychiatric conditions that significantly 
impair the quality of life. For example, OSAS may be associated with depression in 
adolescents and with Down Syndrome in young adults [37]. These macroscopic effects are 
the result of deep physiological alterations. In fact, at cellular level, OSAS can cause 
intermittent hypoxia, hormonal imbalance, and/or systemic inflammation which may 
influence cognitive functions [38]. However, in patients with OSAS, mental fatigue and 
cognitive impairment are directly correlated to the severity of nocturnal disordered 
breathing [39]. Clearly, the severity of the pathology is very important because a cognitive 
consequence is expected only in severe and advanced cases, not in recently diagnosed 
OSAS patients with minimal co-morbidities [40], or in suspected cases identified during 
screening.  
Mood disorders in patients with OSAS have also been studied, especially in relation to the 
way in which these problems may affect adherence to treatment; however the nature of 
the relationship between OSAS and depression and anxiety is still unclear [41]. In fact, 
recent research on depression and anxiety in obstructive sleep apnea syndrome led to 
inconsistent findings: prevalence figures fluctuated considerably for both depression (7-
63%) and anxiety (11-70%) [42]. Moreover, the  reported associations were often 
contrasting. In some cross-sectional studies, OSAS patients had higher scores for 
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depression and anxiety than the control group [43], while in other studies, OSAS was not 
associated with severe symptoms of  depression and anxiety [44]. These differences are 
probably due to the methods used to measure psychological disorders. 
In the present study, we used a particularly sensitive tool to measure mental health. The 
GHQ is possibly the most common assessment of mental well-being [45]. In fact, it is used 
to detect minor psychiatric (non-psychotic) disorders in the general population and within 
community or non-psychiatric clinical settings. It focuses on two main areas: inability to 
carry out normal functions and the appearance of new and distressing psychological 
phenomena. The GHQ assesses the respondent’s current state and determines whether it 
differs from his or her usual state. Therefore, it is sensitive to short-term psychiatric 
disorders, but not to long-standing attributes of the respondent. This instrument, which was 
designed to detect psychiatric morbidity, has also performed very well in trans-cultural 
comparisons of community-based populations [46]. We can therefore assume that the 
GHQ measures an early, and possibly transient worsening of psychological conditions in 
workers with recent onset of sleep apnea. We conclude, in accordance with the literature, 
that the relationships between early-stage OSA and psychological disturbances are weak 
but significant. 
In our study, prevalence values for metabolic syndrome were lower than those estimated 
in the general Italian population and other industrialized countries. The third National 
Health and Nutrition Examination Survey (NHANES III) recorded a 21.8% prevalence of 
metabolic syndrome in the total population [47]. In NHANES III the prevalence of 
abdominal obesity was approximately 50% in females and 30% in males. This was also 
higher than the value found in our study, as were the US population levels of impaired 
HDL-cholesterol, hyperglycemia and hypertension. The few data available for Italy confirm 
that metabolic syndrome and its components occur more frequently than was observed in 
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our sample. The Italian Longitudinal Study on Aging (ILSA) reported a metabolic syndrome 
prevalence of 25.9% [48]. A study conducted in the Marche Region of Italy found a 
metabolic syndrome prevalence of 11.5% in the 36 to 42 age group and of 22.5% in 
subjects between the age of 43 and 60 years [49]. This demonstrated that in our sample 
group at least, the health level of employees was higher than that of the general population 
– a fact that must be taken into account in the planning of action for health. It also 
indicated that the subjects taking part in our study were not prompted in because they 
were suffering from one of the pathologies under investigation. This was important since 
we know that being affected by any morbid condition induces individuals to be more 
precise when recalling all the possible causal factors for that illness. This phenomenon, 
known as “recall bias”, can give rise to fictitious associations. Compared with what may 
occur in case-control studies, the limited number of sick subjects in our survey reduced the 
impact of such an effect. 
Unfortunately, in our study, the majority of workers with suspected OSAS failed to respond 
to advice suggesting they undergo other tests to confirm the diagnosis. In the few cases in 
which subjects followed the advice of the occupational physician, a significant clinical 
improvement was observed. 
This experience demonstrated that health promotion during compulsory health surveillance 
is effective in only a limited number of workers. The main reason for ignoring the 
physician’s advice seemed to be unawareness on the part of the workers of the 
importance of the detrimental effects of OSAS. A multilevel effort that includes specific 
information about the health risks associated with OSAS and incentives for workers who 
participate in the programs proposed, might effectively help to safeguard workers’ health. 
Since small enterprises lack financial resources and training structures, these services 
must be provided by public or consortium facilities. 
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The main limitation of this study concerned sample selection, as all the companies were 
located in the same region and were under the health surveillance of the same doctor 
(NM). These conditions obviously prevented us from extending our findings to other 
situations. One of the strengths of the study was the high level of participation at baseline. 
Another  strength was the inclusion of general workers in the study population. Previous 
studies on the prevalence and risk factors of occupational OSAS had mainly targeted at-
risk workers, so that results were not applicable to a more general population of workers. A 
further strength was the broad set of clinical issues examined; these included an objective 
evaluation of the risk of OSAS, an assessment of sleepiness, blood tests and clinical 
examination to diagnose metabolic syndrome and screening for psychological disorders. 
All these tests were included during the routine medical surveillance of workers without a 
significant burden of time for the performance of medical examinations.  
The data collected show that OSAS is an important risk factor that is widely prevalent in 
the general population of workers, and that this syndrome is strongly correlated with  
metabolic syndrome and mental disorders. It is therefore an ideal candidate for health 
intervention. 
Health promotion programs conducted in small enterprises and based exclusively on 
services provided by the NHS, without a spending commitment for training and incentives 
on the part of employers, have a beneficial but limited impact on the health of workers. 
Only a few workers accepted the invitation of the occupational physician to undergo more 
specialized tests to confirm or refute the diagnosis of OSAS. However, excellent results 
were obtained for those who followed this advice. We are confident that a prevention 
program comprising educational, health and organizational activities could actually prevent 







Table 1. Medical and demographic data for participants. 
 
Variable Male Female p Whole group 
Gender, N (%) 108 (52.9) 96 (47.1)  204 (100) 
Age, years (mean + s.d.) 41.3 + 9.4 40.8 + 9.0 n.s.1 41.1 + 9.2 
Length of work, years 13.2 + 9.7 14.6 + 8.3 n.s.1 13.8 + 9.1 
Smoker, N (%) 46 (42.6) 30 (31.2) n.s.2 76 (37.3) 
Alcohol, 1-7 units/week 51 (47.7) 28 (29.2) <0.0112 79 (38.9) 
Alcohol, 8-16 units/week   7 (6.5)   4 (4.2) 11 (5.4) 
BMI (mean + s.d.) 25.8+3.7 23.0+4.5 <0.0001 24.5+4.3 
Enlarged neck circumference 21 (19.4)  2 (2.1) <0.0002 23 (11.3) 
Increased neck-chin angle 44 (40.7) 22 (22.9) <0.0072 66 (32.4) 
Mallampati grade 3 or 4 24 (22.2) 10 (10.4) <0.0242 34 (16.7) 
ESS (range 0-24) 3.5 + 2.5 3.9 + 3.3 n.s.1 3.7 + 2.9 
SDS (range 0-4) 0.99+1.0 0.69+0.85 <0.0251 0.85 + 0.97 
GHQ (range 12-48) 21.9 + 3.5 22.7 + 5.6 n.s.1 22.2 + 4.6 
 





Table 2. Association between suspected OSAS and personal factors (age, sex, smoking habit, 
alcohol use, lack of physical exercise) and the presence of at least one components of metabolic 
syndrome (obesity, hypertension, dyslipidemia, diabetes). 
 
 
 Predictors  p value 
 OR 95%CI  
OSAS  3.831 1.449-10.129  0.007 
Age 1.073 1.031-1.116  0.001 
Sex 0.395 0.185-0.842  0.016 
Smoker 1.349 0.645-2.822  0.426 
Alcohol use 0.777 0.414-1.458  0.432 
Lack of physical 
activity 
1.878 





Table 3. Associations between suspected OSAS and personal factors (age, sex, smoking habit, 
alcohol use, lack of physical exercise) and GHQ12 score in the highest quartile. 
 
 Predictors p value 
 OR 95%CI 
OSAS 4.668 1.724-12.640 0.002 
Age 1.015 0.975-1.057 0.463 
Sex 3.656 1.619-8.257 0.002 
Smoker 1.306 0.604-2.826 0.497 
Alcohol use 1.236 0.667-2.290 0.500 
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